Location · New Windsor, NY
Clinical trials in New Windsor, NY
11 recruiting studies have a site in New Windsor, and 1 of them accept healthy volunteers.
11 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Collection of Samples USOPTIVAL Study
Universal Diagnostics
- Location
- New Windsor, NY + 3 other US sites
- Eligibility basics
- Ages 45–84
- RecruitingPhase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sanofi
- Location
- New Windsor, NY + 70 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 2
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Merck Sharp & Dohme LLC
- Location
- New Windsor, NY + 34 other US sites
- Eligibility basics
- Ages 50–85
- RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Bristol-Myers Squibb
- Location
- New Windsor, NY + 21 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Celgene
- Location
- New Windsor, NY + 31 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 3
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
GlaxoSmithKline
- Location
- New Windsor, NY + 50 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
AstraZeneca
- Location
- New Windsor, NY + 120 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Location
- New Windsor, NY + 43 other US sites
- Eligibility basics
- Ages 55–90
- RecruitingPhase 2
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
GlaxoSmithKline
- Location
- New Windsor, NY + 93 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and…
Novo Nordisk A/S
- Location
- New Windsor, NY + 55 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- New Windsor, NY + 69 other US sites
- Eligibility basics
- Ages 18–80